SANOFI Covid Vaccine Study

A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older.

Leave A Comment

if (have_posts()) while (have_posts()) : the_post(); the_title(); the_content(); wp_link_pages(); endif; endwhile;